Viewing Study NCT05824468


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2026-01-02 @ 2:42 AM
Study NCT ID: NCT05824468
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-04-21
First Post: 2023-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module